Información:
Error:
ID
16474
Descripción
Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00398333
Link
https://clinicaltrials.gov/show/NCT00398333
Palabras clave
Versiones (1)
- 17/7/16 17/7/16 -
Subido en
17 de julio de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Colorectal Neoplasms NCT00398333
Eligibility Colorectal Neoplasms NCT00398333
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Neoplasms NCT00398333
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Metastatic colon adenocarcinoma
Item
patients diagnosed of metastatic colon adenocarcinoma that are going to receive first line chemotherapy treatment in the oncology day hospital.
boolean
C0338106 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
Age
Item
age over 18 years old.
boolean
C0001779 (UMLS CUI [1])
Second line chemotherapy
Item
patients diagnosed of colon cancer are receiving second line chemotherapy.
boolean
C1710038 (UMLS CUI [1,1])
C0699790 (UMLS CUI [1,2])
C0699790 (UMLS CUI [1,2])
Malignancy
Item
antecedents of other malignant tumors with the exception of basocellular epithelioma.
boolean
C0006826 (UMLS CUI [1])
Chronic renal failure
Item
chronic renal failure (creatinine > 1.7).
boolean
C0201976 (UMLS CUI [1])
Diabetes mellitus
Item
previous diabetes mellitus.
boolean
C0011849 (UMLS CUI [1])
Obesity
Item
obesity (imc > 30)
boolean
C1305855 (UMLS CUI [1])
Hepatic encephalopathy or ascites
Item
medical conditions that imply hepatic encephalopathy, or ascites.
boolean
C0019151 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0003962 (UMLS CUI [2])
Malnutrition
Item
severe malnutrition according to the classification of the subjective global assessment (sga) or a bmi < 16.5.
boolean
C1305855 (UMLS CUI [1])
Psychiatric disorder
Item
major psychiatric disorder.
boolean
C0004936 (UMLS CUI [1])
enteral or parenteral nutrition
Item
patients receiving enteral or parenteral nutrition.
boolean
C0014327 (UMLS CUI [1])
C0030547 (UMLS CUI [2])
C0030547 (UMLS CUI [2])
Galactosemia
Item
contraindications for the indication of the nutritional supplement: galactosemia.
boolean
C0016952 (UMLS CUI [1])
seafood allergy
Item
seafood or seafood byproducts allergy.
boolean
C0685900 (UMLS CUI [1])
Drugs that affect the metabolism
Item
patients taking drugs that affect the metabolism (anabolic steroids, orexigenic agents...).
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0025519 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0025519 (UMLS CUI [1,3])
Informed Consent
Item
absence of the informed consent form signed by the patient.
boolean
C0021430 (UMLS CUI [1])
Disability to comply with the treatment or inability according to the researcher
Item
any patient who has disability to comply with the treatment or who has inability according to the researcher.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])